References
- Global Initiative for Asthma. Global Burden of Asthma May 2004 Available from: http://www.ginasthma.com/GuidelinesResources.asp?l1=2&l2=0. Accessed Mar 2, 2010.
- GuptaRSheikhAStrachanDPAndersonHRBurden of allergic disease in the UK: secondary analyses of national databasesClin Exp Allergy20043452052615080802
- AsthmaUKNew data reveals high cost of asthma2009 Available from: http://www.asthma.org.uk/news_media/news/new_data_reveals_hig.html. Accessed February 25, 2010.
- AsthmaUKWhere do we stand? Asthma in the UK today2004 Available from: http://www.asthma.org.uk/health_professionals/ordering_materials/where_do_we_stand.html. Accessed Mar 2, 2010.
- BarnesPJJonssonBKlimJBThe costs of asthmaEur Respir J199696366428726924
- CisternasMGBlancPDYenIHA comprehensive study of the direct and indirect costs of adult asthmaJ Allergy Clin Immunol20031111212121812789219
- SullivanSDRasouliyanLRussoPAKamathTChippsBEExtent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthmaAllergy20076212613317298420
- RabeKFVermeirePASorianoJBMaierWCClinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J20001680280711153575
- BouletLPPhillipsRO’ByrnePBeckerAEvaluation of asthma control by physicians and patients: comparison with current guidelinesCan Respir J2002941742312522488
- RabeKFAdachiMLaiCKWorldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJ Allergy Clin Immunol2004114404715241342
- HaughneyJPriceDKaplanAAchieving asthma control in practice: understanding the reasons for poor controlRespir Med20081021681169318815019
- CromptonGKBarnesPJBroedersMThe need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement TeamRespir Med20061001479149416495040
- ChrystynHPriceDNot all asthma inhalers are the same: factors to consider when prescribing an inhalerPrim Care Respir J20091824324919513494
- GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J200221924625111866004
- LenneyJInnesJACromptonGKInappropriate inhaler use: assessment of use and patient preference of seven inhalation devicesRespir Med20009449650010868714
- MolimardMRaherisonCLignotSDepontFAbouelfathAMooreNAssessment of handling of inhaler devices in real life: An observational study in 3811 patients in primary careJ Aerosol Med20031624925414572322
- BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technol Assess20015114911701099
- BrocklebankDWrightJCatesCSystematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthmaBMJ2001323731889690011668133
- DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest200512733537115654001
- HerlandKAkselsenJPSkjonsbergOHBjermerLHow representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?Respir Med200599111915672843
- TraversJMarshSWilliamsMExternal validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax20076221922317105779
- ConcatoJHorwitzRIBeyond randomised versus observational studiesLancet200436394221660166115158623
- ConcatoJShahNHorwitzRIRandomized, controlled trials, observational studies, and the hierarchy of research designsN Engl J Med20003421887189210861325
- CampbellJDSpackmanDESullivanSDHealth economics of asthma: assessing the value of asthma interventionsAllergy2008631581159219032230
- ThomasMClelandJPriceDDatabase studies in asthma pharmacoeconomics: uses, limitations and quality markersExpert Opin Pharmacother2003435135812614187
- PriceDThomasMMitchellGNiziolCFeatherstoneRImprovement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated deviceRespir Med200397121912556005
- General Practice Research Database2010 Available from: http://www.gprd.com/. Accessed Mar 2, 2010.
- HansellAHollowellJNicholsTMcNieceRStrachanDUse of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4)Thorax19995441341910212105
- HollowellJThe General Practice Research Database: quality of morbidity dataPopul Trends1997Spring8736409134574
- JickSSKayeJAVasilakis-ScaramozzaCValidity of the General Practice Research DatabasePharmacotherapy20032368668912741446
- Research in Real Life: Standard Operating Procedures Available from: http://www.optimumpatientcare.org/downloads/documents/SOP%20observational%20database%20studies.pdf. Accessed Mar 2, 2010.
- Global Initiative for Asthma (GINA)Global Strategy for Asthma Management and Prevention, updated 2009 Available from: http://www.ginasthma.org. Accessed February 25, 2010.
- Department of HealthNHS reference costs 2007–082009 Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_098945. Accessed Mar 2, 2010.
- CurtisLUnit Costs of Health and Social Care 2007 Personal Social Services Research Unit. University of Kent; 2007. Available from: http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007.pdf. Accessed Mar 2, 2010.
- The NHS Information Centre Prescribing Support Unit. Prescription Cost Analysis for England 2007 Data by individual preparation; 2008. Available from: http://www.ic.nhs.uk/statistics-and-data-collections/primary-care/prescriptions/prescription-cost-analysis-2007. Accessed Mar 2, 2010.
- British National FormularyV 54 edLonden, UkBritish Medical Association and the Royal Pharma ceutical society of Great Britain2007
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
- HeitjanDFMoskowitzAJWhangWProblems with interval estimates of the incremental cost-effectiveness ratioMed Decis Making1999199159917015
- HochJSBriggsAHWillanARSomething old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysisHealth Econ20021141543012112491
- O’BrienBJBriggsAHAnalysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methodsStat Methods Med Res20021145546812516984
- BriggsAHBousquetJWallaceMVCost-effectiveness of asthma control: an economic appraisal of the GOAL studyAllergy20066153153616629780
- SculpherMJPriceMMeasuring costs and consequences in economic evaluation in asthmaRespir Med20039750852012735668
- LiljasBStadhlEPauwelsRACost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthmaPharmacoeconomics1997122 Pt 226727710170451
- KellowayJSWyattRA cost-effectiveness analysis of breath-actuated metered-dose inhalersManag Care Interface1997109910710175551
- IMS Health Available from: http://www.imshealth.com. Accessed January 28, 2010.
- ReddelHKTaylorDRBatemanEDAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceAm J Respir Crit Care Med2009180599919535666